Revlimid Archives - Biostock

Lower sales for Covid-19 products

Covid-19 products face tougher future

FDA

Fewer approvals in 2022 from cautious FDA

After approving an average of 51 drugs...

DexTech takes a new approach to myeloma treatment

DexTech takes a new approach to myeloma treatment

Uppsala-based DexTech is in full swing with preparations...